Financial Architects (New Jersey)’s Clovis Oncology, Inc. CLVS Stock Holding History

Financial Architects (New Jersey)’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-450	Closed	-$11K	–	1538
2019 Q1	$11K	Hold	450	–	–	﹤0.01%	1072
2018 Q4	$8K	Hold	450	–	–	﹤0.01%	1050
2018 Q3	$13K	Hold	450	–	–	﹤0.01%	1052
2018 Q2	$20K	Hold	450	–	–	﹤0.01%	814
2018 Q1	$24K	Buy	450 +350	+350%	+$20.4K	﹤0.01%	837
2017 Q4	$7K	Buy	+100	New	+$6.99K	﹤0.01%	1238
2017 Q2	–	Sell	-300	Closed	-$19K	–	1667
2017 Q1	$19K	Buy	+300	New	+$18.2K	﹤0.01%	955
2016 Q4	–	Sell	-100	Closed	-$4K	–	1533
2016 Q3	$4K	Buy	+100	New	+$2.15K	﹤0.01%	1216
2015 Q3	–	Sell	-2,000	Closed	-$176K	–	994
2015 Q2	$176K	Buy	+2,000	New	+$171K	0.06%	211

Other funds holding CLVS

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Financial Architects (New Jersey)'s CLVS Position: Q2 2019 in Review

Financial Architects (New Jersey) sold out of Clovis Oncology, Inc. (CLVS) in Q2 2019, closing a stake of 450 shares — an estimated $11K sold.

Financial Architects (New Jersey) first reported a position in CLVS in Q2 2015 and held it in 9 quarters. The position peaked at $176K in Q2 2015. 167 funds tracked by Wall St. Rank hold CLVS as of Q2 2019.

Financial Architects (New Jersey) reported no remaining Clovis Oncology, Inc. position as of Q2 2019 after selling out during the quarter.
Financial Architects (New Jersey) sold 450 Clovis Oncology, Inc. shares in Q2 2019, an estimated $11K.
Financial Architects (New Jersey) first reported a position in Clovis Oncology, Inc. in Q2 2015 and held it in 9 quarters.
Financial Architects (New Jersey)'s Clovis Oncology, Inc. position peaked at $176K in Q2 2015.
167 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2019.

Based on Financial Architects (New Jersey)'s 13F filing for Q2 2019, filed 14 Aug 2019.